Glycemic Control in Type 1 Diabetes Mellitus and COVID-19: What We Learned From the Lockdown Experience
Confinement measures that were imposed during the COVID-19 pandemic drastically changed the routines of the population. Some studies on the impact of confinement on glycemic control suggest a reduction of 0.1 to 0.5% in glycated hemoglobin. The objective of this study was to evaluate the impact of t...
Gespeichert in:
| Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2023-01, Vol.15 (1), p.e33340 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | e33340 |
| container_title | Curēus (Palo Alto, CA) |
| container_volume | 15 |
| creator | Almeida, Catarina Ferreira, André Duarte, Daniela Viegas, Ana Filipa Santos, André Vaz, Alexandra Nascimento, Edite |
| description | Confinement measures that were imposed during the COVID-19 pandemic drastically changed the routines of the population. Some studies on the impact of confinement on glycemic control suggest a reduction of 0.1 to 0.5% in glycated hemoglobin. The objective of this study was to evaluate the impact of the COVID-19 pandemic lockdown on glycemic control in adult patients with type 1 diabetes mellitus.
An observational retrospective cohort study of patients with type 1 diabetes mellitus followed in a Diabetes Unit was performed. The study compared the metabolic control of these patients before (between January 1st and March 18th, 2020) and after (between May 3rd and July 31st, 2020) the lockdown.
The study included 102 patients with type 1 diabetes mellitus (51% females), with a median age of 36 years (interquartile range 18.75, (24.25-43)) and a median duration of diabetes of 15 years (interquartile range 13, (8-21)). After lockdown, a significant decrease of 0.28±0.71% in glycated hemoglobin was observed (7.88±1.33%
7.59±1.23%,
= |
| doi_str_mv | 10.7759/cureus.33340 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2773718226</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2773718226</sourcerecordid><originalsourceid>FETCH-LOGICAL-c244t-80b15e3b4689d8093b71c7535727fe00f30476a359d26aaa26edd3e1fbbc954d3</originalsourceid><addsrcrecordid>eNpdkU1LxDAQhoMo7qLePEvAiwer-WrSepP9UGHFi7rHkiZT7do2a9Ki--_tuquIpxmGh5eXeRA6puRCqTi9NJ2HLlxwzgXZQUNGZRIlNBG7f_YBOgphQQihRDGiyD4acKkElbEYopebamWgLg0euab1rsJlgx9XS8AUj0udQwsB30NVlW0XsG4sHj08340jml7h-atu8RzwDLRvwOKpdzVuX_uDM2_WfTR48rkEX0Jj4BDtFboKcLSdB-hpOnkc3Uazh5u70fUsMkyINkpITmPguZBJahOS8lxRo2IeK6YKIKTgRCipeZxaJrXWTIK1HGiR5yaNheUH6GyTu_TuvYPQZnUZTN9fN-C6kDGluKIJY7JHT_-hC9f5pm_XUwmRXLB0TZ1vKONdCB6KbOnLWvtVRkm2dpBtHGTfDnr8ZBva5TXYX_jn4_wLVnWAMw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2780634296</pqid></control><display><type>article</type><title>Glycemic Control in Type 1 Diabetes Mellitus and COVID-19: What We Learned From the Lockdown Experience</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Almeida, Catarina ; Ferreira, André ; Duarte, Daniela ; Viegas, Ana Filipa ; Santos, André ; Vaz, Alexandra ; Nascimento, Edite</creator><creatorcontrib>Almeida, Catarina ; Ferreira, André ; Duarte, Daniela ; Viegas, Ana Filipa ; Santos, André ; Vaz, Alexandra ; Nascimento, Edite</creatorcontrib><description>Confinement measures that were imposed during the COVID-19 pandemic drastically changed the routines of the population. Some studies on the impact of confinement on glycemic control suggest a reduction of 0.1 to 0.5% in glycated hemoglobin. The objective of this study was to evaluate the impact of the COVID-19 pandemic lockdown on glycemic control in adult patients with type 1 diabetes mellitus.
An observational retrospective cohort study of patients with type 1 diabetes mellitus followed in a Diabetes Unit was performed. The study compared the metabolic control of these patients before (between January 1st and March 18th, 2020) and after (between May 3rd and July 31st, 2020) the lockdown.
The study included 102 patients with type 1 diabetes mellitus (51% females), with a median age of 36 years (interquartile range 18.75, (24.25-43)) and a median duration of diabetes of 15 years (interquartile range 13, (8-21)). After lockdown, a significant decrease of 0.28±0.71% in glycated hemoglobin was observed (7.88±1.33%
7.59±1.23%,
=<0.001). In patients using continuous glucose monitoring a significant improvement in time in range was also noted (47.25±17.33%
49.97±18.61%,
=0.008).
This study demonstrated an improvement in glycemic control after the lockdown. This might be explained by the positive impact of stable schedules, healthy meals and greater availability to make therapeutic adjustments to glycemic control. The fact that diabetes was considered a risk factor for the development of severe COVID-19 disease might also influence patients to increase their efforts to optimize their glycemic control.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.33340</identifier><identifier>PMID: 36741654</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>COVID-19 ; Diabetes ; Disease ; Glucose monitoring ; Health care access ; Hemoglobin ; Insulin ; Metabolism ; Pandemics ; Severe acute respiratory syndrome coronavirus 2</subject><ispartof>Curēus (Palo Alto, CA), 2023-01, Vol.15 (1), p.e33340</ispartof><rights>Copyright © 2023, Almeida et al.</rights><rights>Copyright © 2023, Almeida et al. This work is published under https://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c244t-80b15e3b4689d8093b71c7535727fe00f30476a359d26aaa26edd3e1fbbc954d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36741654$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Almeida, Catarina</creatorcontrib><creatorcontrib>Ferreira, André</creatorcontrib><creatorcontrib>Duarte, Daniela</creatorcontrib><creatorcontrib>Viegas, Ana Filipa</creatorcontrib><creatorcontrib>Santos, André</creatorcontrib><creatorcontrib>Vaz, Alexandra</creatorcontrib><creatorcontrib>Nascimento, Edite</creatorcontrib><title>Glycemic Control in Type 1 Diabetes Mellitus and COVID-19: What We Learned From the Lockdown Experience</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Confinement measures that were imposed during the COVID-19 pandemic drastically changed the routines of the population. Some studies on the impact of confinement on glycemic control suggest a reduction of 0.1 to 0.5% in glycated hemoglobin. The objective of this study was to evaluate the impact of the COVID-19 pandemic lockdown on glycemic control in adult patients with type 1 diabetes mellitus.
An observational retrospective cohort study of patients with type 1 diabetes mellitus followed in a Diabetes Unit was performed. The study compared the metabolic control of these patients before (between January 1st and March 18th, 2020) and after (between May 3rd and July 31st, 2020) the lockdown.
The study included 102 patients with type 1 diabetes mellitus (51% females), with a median age of 36 years (interquartile range 18.75, (24.25-43)) and a median duration of diabetes of 15 years (interquartile range 13, (8-21)). After lockdown, a significant decrease of 0.28±0.71% in glycated hemoglobin was observed (7.88±1.33%
7.59±1.23%,
=<0.001). In patients using continuous glucose monitoring a significant improvement in time in range was also noted (47.25±17.33%
49.97±18.61%,
=0.008).
This study demonstrated an improvement in glycemic control after the lockdown. This might be explained by the positive impact of stable schedules, healthy meals and greater availability to make therapeutic adjustments to glycemic control. The fact that diabetes was considered a risk factor for the development of severe COVID-19 disease might also influence patients to increase their efforts to optimize their glycemic control.</description><subject>COVID-19</subject><subject>Diabetes</subject><subject>Disease</subject><subject>Glucose monitoring</subject><subject>Health care access</subject><subject>Hemoglobin</subject><subject>Insulin</subject><subject>Metabolism</subject><subject>Pandemics</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkU1LxDAQhoMo7qLePEvAiwer-WrSepP9UGHFi7rHkiZT7do2a9Ki--_tuquIpxmGh5eXeRA6puRCqTi9NJ2HLlxwzgXZQUNGZRIlNBG7f_YBOgphQQihRDGiyD4acKkElbEYopebamWgLg0euab1rsJlgx9XS8AUj0udQwsB30NVlW0XsG4sHj08340jml7h-atu8RzwDLRvwOKpdzVuX_uDM2_WfTR48rkEX0Jj4BDtFboKcLSdB-hpOnkc3Uazh5u70fUsMkyINkpITmPguZBJahOS8lxRo2IeK6YKIKTgRCipeZxaJrXWTIK1HGiR5yaNheUH6GyTu_TuvYPQZnUZTN9fN-C6kDGluKIJY7JHT_-hC9f5pm_XUwmRXLB0TZ1vKONdCB6KbOnLWvtVRkm2dpBtHGTfDnr8ZBva5TXYX_jn4_wLVnWAMw</recordid><startdate>202301</startdate><enddate>202301</enddate><creator>Almeida, Catarina</creator><creator>Ferreira, André</creator><creator>Duarte, Daniela</creator><creator>Viegas, Ana Filipa</creator><creator>Santos, André</creator><creator>Vaz, Alexandra</creator><creator>Nascimento, Edite</creator><general>Cureus Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>202301</creationdate><title>Glycemic Control in Type 1 Diabetes Mellitus and COVID-19: What We Learned From the Lockdown Experience</title><author>Almeida, Catarina ; Ferreira, André ; Duarte, Daniela ; Viegas, Ana Filipa ; Santos, André ; Vaz, Alexandra ; Nascimento, Edite</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c244t-80b15e3b4689d8093b71c7535727fe00f30476a359d26aaa26edd3e1fbbc954d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>COVID-19</topic><topic>Diabetes</topic><topic>Disease</topic><topic>Glucose monitoring</topic><topic>Health care access</topic><topic>Hemoglobin</topic><topic>Insulin</topic><topic>Metabolism</topic><topic>Pandemics</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Almeida, Catarina</creatorcontrib><creatorcontrib>Ferreira, André</creatorcontrib><creatorcontrib>Duarte, Daniela</creatorcontrib><creatorcontrib>Viegas, Ana Filipa</creatorcontrib><creatorcontrib>Santos, André</creatorcontrib><creatorcontrib>Vaz, Alexandra</creatorcontrib><creatorcontrib>Nascimento, Edite</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Almeida, Catarina</au><au>Ferreira, André</au><au>Duarte, Daniela</au><au>Viegas, Ana Filipa</au><au>Santos, André</au><au>Vaz, Alexandra</au><au>Nascimento, Edite</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glycemic Control in Type 1 Diabetes Mellitus and COVID-19: What We Learned From the Lockdown Experience</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2023-01</date><risdate>2023</risdate><volume>15</volume><issue>1</issue><spage>e33340</spage><pages>e33340-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Confinement measures that were imposed during the COVID-19 pandemic drastically changed the routines of the population. Some studies on the impact of confinement on glycemic control suggest a reduction of 0.1 to 0.5% in glycated hemoglobin. The objective of this study was to evaluate the impact of the COVID-19 pandemic lockdown on glycemic control in adult patients with type 1 diabetes mellitus.
An observational retrospective cohort study of patients with type 1 diabetes mellitus followed in a Diabetes Unit was performed. The study compared the metabolic control of these patients before (between January 1st and March 18th, 2020) and after (between May 3rd and July 31st, 2020) the lockdown.
The study included 102 patients with type 1 diabetes mellitus (51% females), with a median age of 36 years (interquartile range 18.75, (24.25-43)) and a median duration of diabetes of 15 years (interquartile range 13, (8-21)). After lockdown, a significant decrease of 0.28±0.71% in glycated hemoglobin was observed (7.88±1.33%
7.59±1.23%,
=<0.001). In patients using continuous glucose monitoring a significant improvement in time in range was also noted (47.25±17.33%
49.97±18.61%,
=0.008).
This study demonstrated an improvement in glycemic control after the lockdown. This might be explained by the positive impact of stable schedules, healthy meals and greater availability to make therapeutic adjustments to glycemic control. The fact that diabetes was considered a risk factor for the development of severe COVID-19 disease might also influence patients to increase their efforts to optimize their glycemic control.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>36741654</pmid><doi>10.7759/cureus.33340</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2168-8184 |
| ispartof | Curēus (Palo Alto, CA), 2023-01, Vol.15 (1), p.e33340 |
| issn | 2168-8184 2168-8184 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2773718226 |
| source | PubMed Central Open Access; PubMed Central |
| subjects | COVID-19 Diabetes Disease Glucose monitoring Health care access Hemoglobin Insulin Metabolism Pandemics Severe acute respiratory syndrome coronavirus 2 |
| title | Glycemic Control in Type 1 Diabetes Mellitus and COVID-19: What We Learned From the Lockdown Experience |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T20%3A37%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glycemic%20Control%20in%20Type%201%20Diabetes%20Mellitus%20and%20COVID-19:%20What%20We%20Learned%20From%20the%20Lockdown%20Experience&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Almeida,%20Catarina&rft.date=2023-01&rft.volume=15&rft.issue=1&rft.spage=e33340&rft.pages=e33340-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.33340&rft_dat=%3Cproquest_cross%3E2773718226%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2780634296&rft_id=info:pmid/36741654&rfr_iscdi=true |